Deltec Asset Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Deltec Asset Management’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,138	Closed	-$255K	–	185
2017 Q1	$255K	Sell	2,138 -3,750	-64%	-$393K	0.05%	146
2016 Q4	$585K	Sell	5,888 -3,487	-37%	-$367K	0.14%	109
2016 Q3	$1.05M	Buy	9,375 +8,062	+614%	+$968K	0.24%	80
2016 Q2	$135K	Sell	1,313 -2,804	-68%	-$280K	0.03%	134
2016 Q1	$378K	Sell	4,117 -13,536	-77%	-$1.44M	0.09%	103
2015 Q4	$2.55M	Sell	17,653 -2,649	-13%	-$345K	0.65%	42
2015 Q3	$2.1M	Buy	+20,302	New	+$2.38M	0.52%	49

Other funds holding SIOX

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Deltec Asset Management's SIOX Position: Q2 2017 in Review

Deltec Asset Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2017, closing a stake of 2,138 shares — an estimated $255K sold.

Deltec Asset Management first reported a position in SIOX in Q3 2015 and held it in 7 quarters. The position peaked at $2.55M in Q4 2015. 113 funds tracked by Wall St. Rank hold SIOX as of Q2 2017.

Deltec Asset Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Deltec Asset Management sold 2,138 Sio Gene Therapies Inc. Common Stock shares in Q2 2017, an estimated $255K.
Deltec Asset Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 7 quarters.
Deltec Asset Management's Sio Gene Therapies Inc. Common Stock position peaked at $2.55M in Q4 2015.
113 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2017.

Based on Deltec Asset Management's 13F filing for Q2 2017, filed 24 Jul 2017.